Menu
Search
|

Menu

Close
X

Microbot Medical Inc MBOT.OQ (NASDAQ Stock Exchange Capital Market)

0.64 USD
-0.00 (-0.08%)
As of 12:00 AM EDT
chart
Previous Close 0.64
Open 0.60
Volume 73,150
3m Avg Volume 35,062
Today’s High 0.67
Today’s Low 0.60
52 Week High 1.55
52 Week Low 0.58
Shares Outstanding (mil) 42.12
Market Capitalization (mil) 28.31
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
0
FY15
0
EPS (USD)
FY18
-0.035
FY17
-0.204
FY16
-0.069
FY15
-33.860
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.05
Price to Sales (TTM)
vs sector
--
8.10
Price to Book (MRQ)
vs sector
2.15
4.20
Price to Cash Flow (TTM)
vs sector
--
22.23
Total Debt to Equity (MRQ)
vs sector
0.00
17.32
LT Debt to Equity (MRQ)
vs sector
0.00
13.18
Return on Investment (TTM)
vs sector
-108.52
13.17
Return on Equity (TTM)
vs sector
-112.33
15.10

EXECUTIVE LEADERSHIP

Harel Gadot
Chairman of the Board, President, Chief Executive Officer, Since 2016
Salary: $275,000.00
Bonus: --
David Ben Naim
Chief Financial Officer, Since 2016
Salary: $6,000.00
Bonus: --
Yehezkel Himelfarb
Chief Operating Officer, General Manager - Israeli Operations, Since 2016
Salary: $16,000.00
Bonus: --
Simon Sharon
Chief Technology Officer, Since 2018
Salary: --
Bonus: --
Yoseph Bornstein
Director, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

175 Derby St # 27/1
HINGHAM   MA   02043-4007

Phone: +1908.9385561

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company's TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.

SPONSORED STORIES